PHE COVID-19 vaccination guidance
On 31 December 2019, the World Health Organization (WHO) was informed of a cluster of cases of pneumonia of unknown cause detected in Wuhan City, China. On 12 January 2020, it was announced that a novel coronavirus was identified as the cause of the illnesses being detected. This virus is referred to as SARS-CoV-2, and the associated disease as COVID-19.
On 30 January 2020, the WHO Emergency Committee agreed that the outbreak met the criteria for a Public Health Emergency of International Concern and on 11 March 2020, the WHO declared COVID-19 as a pandemic.
On 02 December 2020, the UK Department of Health and Social Care and the Medicines and Healthcare products Regulatory Agency authorised the temporary supply of the COVID-19 mRNA Vaccine BNT162b2 (Pfizer-BioNTech), and on 30 December 2020, authorised the temporary supply of the COVID-19 Vaccine AstraZeneca.
On 08 January 2021, the COVID-19 Vaccine Moderna was given authorisation for temporary supply by the MHRA. It is not currently available in the UK